Canada House Wellness Group Reports Third Quarter Fiscal Year 2020 Results and Provides Business Update Regarding COVID-19

CALGARY, Alberta, May 06, 2020 (GLOBE NEWSWIRE) -- Parkland Fuel Corporation ("Parkland", "we", the "Company", or "our") (TSX:PKI) announced today its financial and operating results for the three months ended March 31, 2020. First quar.....»»

ATLANTA, May 6, 2020 /PRNewswire/.....»»

Fourth quarter net sales were flat at $119.0 million and comparable sales increased 1% Fourth quarter GAAP loss per share was $3.97 Fourth quarter adjusted loss per share was $0.31 (see No.....»»

WESTFORD, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE:KAI) reported its financial results for the first quarter ended March 28, 2020. Business Update Related to COVID-19 Designated by the U.S. Department of Homeland .....»»

NEW ALBANY, Ohio, April 28, 2020 /PRNewswire/ -- Commercial Vehicle Group, Inc. (the "company".....»»

Announces Fourth Fiscal Quarter and Full Year 2020 Financial Results Conference Call MONTREAL, April 8, 2020 /PRNewswire/ - Lightspeed POS Inc. ("Lightspeed" or the "Company") (TSX: LSPD), a leading cloud-based com.....»»

MONTREAL, March 26, 2020 /CNW/ - LXRandCo, Inc. ("LXRandCo" or the "Company") (TSX:LXR, LXR.WT)), a North American omni-channel .....»»

LEXINGTON, Mass., March 19, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focus.....»»

PALO ALTO, Calif., March 13, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial resul.....»»

XERMELO® (telotristat ethyl) 2019 U.S. Net Sales Reached $31.0 Million THE WOODLANDS, Texas, March 12, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), today reported financial results for the three .....»»

MONTREAL, March 11, 2020 (GLOBE NEWSWIRE) -- IPL Plastics Inc. ("IPL Plastics", "IPLP", the "Group" or the "Company") (TSX:IPLP) today reported financial results for the fourth quarter and Fiscal year ended December 31, 2019 (.....»»

-Presented initial clinical data for lead allogeneic CAR T program PBCAR0191 for the treatment of NHL and B-ALL- -Implemented amendment to PBCAR0191 Phase 1/2a trial focused on optimizing clinical activity,.....»»

Reports 78% increase in revenue and 92% increase in gross profit for fiscal 2019 Generated over $3.1 million in sales through POCare platform Rapidly expanding POCare platform through new collaborations GERMANTOWN, Md., March 10, 2020 (GLOBE NEWSW.....»»

BERKELEY, Calif., March 09, 2020 (GLOBE NEWSWIRE) -- A.....»»

Grows Customer Base to Over 2.....»»

BRIDGEWATER, N.J., Feb. 25, 2020 /PRNewswire/ -- Insmed Incorporated (N.....»»

SALT LAKE CITY, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Predictive Techno.....»»

InMed Pharmaceuticals Reports Second Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update.....»»

Net Loss Improves to ($0.6) Million as All Three Business Units Deliver Prof.....»»

Marvell Technology Group Ltd. Reports Third Quarter of Fiscal Year 2020 Financial Results.....»»